OBJECTIVE:To investigate the stability of cefoselis sulfate for injection in xylitol injection.METHODS:The mixture of cefoselis sulfate for injection and xylitol injection was observed within 6 h after mixing were observed at 25℃ and 37℃ with regard to its appearance,pH value,and UV spectra of cefoselis.The content of cefoselis sulfate in the mixture was determined by UV spectrophotometry.RESULTS:No marked change was noted for the mixture within 6 hours after mixing in terms of the appearance,pH value,ultraviolet absorption spectra and content.CONCLUSION:Cefoselis sulsate for injection is stable within 6 hours after mixing with xylitol injection.

Objective To explore the risk factors on impact of early dislocation after hip arthroplasty,and provide patients with individ-ualized treatment programs. Methods We retrospectively analyzed the clinical data of displaced femoral neck fractures in 247 patients who accepted hip arthroplasty from January 2006 to December 2011,and a total of 8 potential factors associated with occurrence of early dislocation were evaluated by univariate analysis and multivariate logistic regression analysis. Results The univariate analysis showed that sex,surgical approach and femoral head size were correlated with early dislocation (P<0. 05). Multivariate logistic regression analysis showed that female (OR=1. 862),posterolateral surgical approach (OR=3. 478),the use of 22 mm femoral heads (OR=2. 558)were independent risk factors (P<0. 05). And use of≥30 mm femoral heads(OR=0. 635) was a protective factor(P<0. 05). Conclusion Occurrence of early dislo-cation after hip arthroplasty is mainly correlated with many factors,various risk factors should be taken into account in preoperative and intrao-perative and choose the optimal individualized treatment plan.

OBJECTIVE:To compare the preventive effects and safety of aspirin and clopodogrel respectively used for vascular restenosis after coronary intimal striping with coronary artery bypass grafting. METHODS:110 patients with coronary atherosclerot-ic heart disease were divided into aspirin group (55 cases) and clopodogrel group (55 cases). All patients intravenously mi-cro-pumped Nitroglycerin injection 10 mg+5% Glucose injection totally 20 mL for maintaining 48-72 h after coronary intimal strip-ing with coronary artery bypass grafting,intravenously pumped Dopamine hydrochloride injection 1-5 μg/kg if necessary. Unplug the endotracheal tube after surgery,patients received Cefuroxime sodium for injection 1.5 g adding into Sterile water for injection 50 mL,intravenous injection,3 times a day,for 2-3 d. Meanwhile,patients were orally given Rosuvastatin calcium tablet 10 mg 30 min after daily dinner,8-week was a course,for 3 courses. Based on it,aspirin group received Aspirin enteric-coated tablet with initial dose of 300 mg,once a day,orally taking 100 mg from the second day,once a day,for 6 months;clopodogrel group received Clopidogrel hydrogen sulfate tablet with initial dose of 300 mg,once a day,orally taking 75 mg from the second day, once a day,for 6 months. Graft patency rate,and platelet aggregation rate,platelet aggregation compliance rate,fibrinogen(Fg), D-dimer (D-D),platelet count (PLT),tissue-type plasminogen activator (t-PA) before and after treatment,and the incidence of adverse reactions in 2 groups were observed. RESULTS:There were no significant differences in the graft patency rate and inci-dence of adverse reactions in 2 groups (P>0.05). Before treatment,there were no significant differences in platelet aggregation rate,platelet aggregation compliance rate,Fg,D-D,PLT and t-PA in 2 groups (P>0.05). After treatment,platelet aggregation rate,Fg and D-D level in 2 groups were significantly lower than before,platelet aggregation compliance rate,PLT and t-PA level were significantly higher than before,with statistical significance(P<0.05),while there were no significant differences between 2 groups(P>0.05). CONCLUSIONS:Based on conventional treatment,both aspirin and clopidogrel used for coronary intimal strip-ing with coronary artery bypass grafting can inhibit platelet aggregation,reduce thrombosis,maintain vascular patency and prevent vascular restenosis,with good safety.